Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension

RATIONALE: Demographic characteristics of pulmonary arterial hypertension (PAH) patients have changed over time, but the effects of cardiovascular risk factors on risk status and pulmonary vascular resistance (PVR) reduction with initial oral combination therapy are not known. Therefore, we tested t...

Descripción completa

Detalles Bibliográficos
Autores principales: Badagliacca, Roberto, D'Alto, Michele, Ghio, Stefano, Argiento, Paola, Brunetti, Natale Daniele, Casu, Gavino, Cedrone, Nadia, Confalonieri, Marco, Corda, Marco, Correale, Michele, D'Agostino, Carlo, De Michele, Lucrezia, Di Marino, Serena, Filomena, Domenico, Galgano, Giuseppe, Greco, Alessandra, Lombardi, Carlo, Manzi, Giovanna, Mercurio, Valentina, Mulè, Massimiliano, Paciocco, Giuseppe, Papa, Silvia, Romeo, Emanuele, Scelsi, Laura, Stolfo, Davide, Vitulo, Patrizio, Vizza, Carmine Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638831/
https://www.ncbi.nlm.nih.gov/pubmed/36382240
http://dx.doi.org/10.1183/23120541.00298-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638831/
https://www.ncbi.nlm.nih.gov/pubmed/36382240
http://dx.doi.org/10.1183/23120541.00298-2022

Ejemplares similares